Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Newly granted patent is part of the expanding intellectual property portfolio directed to:

-generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and

Read more at globenewswire.com